Cargando…
Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743637/ https://www.ncbi.nlm.nih.gov/pubmed/34510868 http://dx.doi.org/10.4046/trd.2021.0135 |
| _version_ | 1784629948038774784 |
|---|---|
| author | Kang, Yewon Mok, Jeongha |
| author_facet | Kang, Yewon Mok, Jeongha |
| author_sort | Kang, Yewon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8743637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87436372022-01-24 Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply Kang, Yewon Mok, Jeongha Tuberc Respir Dis (Seoul) Letter to the Editor The Korean Academy of Tuberculosis and Respiratory Diseases 2022-01 2021-09-13 /pmc/articles/PMC8743637/ /pubmed/34510868 http://dx.doi.org/10.4046/trd.2021.0135 Text en Copyright © 2022 The Korean Academy of Tuberculosis and Respiratory Diseases https://creativecommons.org/licenses/by-nc/4.0/It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ). |
| spellingShingle | Letter to the Editor Kang, Yewon Mok, Jeongha Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply |
| title | Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply |
| title_full | Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply |
| title_fullStr | Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply |
| title_full_unstemmed | Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply |
| title_short | Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply |
| title_sort | treatment outcomes of patients with multidrug-resistant tuberculosis: concern to bedaquiline: authors’ reply |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743637/ https://www.ncbi.nlm.nih.gov/pubmed/34510868 http://dx.doi.org/10.4046/trd.2021.0135 |
| work_keys_str_mv | AT kangyewon treatmentoutcomesofpatientswithmultidrugresistanttuberculosisconcerntobedaquilineauthorsreply AT mokjeongha treatmentoutcomesofpatientswithmultidrugresistanttuberculosisconcerntobedaquilineauthorsreply |